Syndexa Pharmaceuticals Headquarters
The links below provide all the necessary information about Syndexa Pharmaceuticals Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Syndexa Pharmaceuticals - Crunchbase Company Profile …
- https://www.crunchbase.com/organization/syndexa-pharmaceuticals
- Contact Email [email protected]. Phone Number 617-607-7283. Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to treat metabolic diseases. Founded by scientists from Harvard University, and led by President and CEO Teo Uysal, Syndexa is dedicated to the discovery and development of a new generation ...
Home - Syndax
- https://syndax.com/
- Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 03.01.22 Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update. 03.01.22 Syndax Pharmaceuticals Announces Appointment of Kate Madigan, M.D., as Chief Medical Officer
Syndexa Pharmaceuticals Corporation in Wilmington, DE
- https://www.bizapedia.com/de/syndexa-pharmaceuticals-corporation.html
- SYNDEXA PHARMACEUTICALS CORPORATION. Syndexa Pharmaceuticals Corporation is a Delaware Corporation filed On February 10, 2005. The company's File Number is listed as 3924118. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, Wilmington, DE 19801.
About Us - Syndax
- https://syndax.com/about/
- About Us. At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company’s pipeline includes SNDX-5613, a highly selective inhibitor of the Menin–MLL ...
Syndax Pharmaceuticals Company Profile - Craft
- https://craft.co/syndax-pharmaceuticals
- Syndax Pharmaceuticals has 35 employees across 3 locations and $1.52 M in annual revenue in FY 2020. See insights on Syndax Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ... Where is Syndax Pharmaceuticals headquarters? Syndax Pharmaceuticals headquarters is located at ...
Syndexa Pharmaceuticals | CXOreach
- https://cxoreach.com/companies/details.php?domain=syndexa.com
- Syndexa Pharmaceuticals is dedicated to the discovery and development of novel therapeutics targeting endoplasmic reticulum (ER) stress.
Syndax Pharmaceuticals Inc - Company Profile and News
- https://www.bloomberg.com/profile/company/SNDX:US
- Company profile page for Syndax Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information
syndexa pharmaceuticals Company Overview
- https://www.definitions.net/definition/syndexa+pharmaceuticals
- Company overview of syndexa pharmaceuticals from the Definitions.net dictionary. Detailed information of syndexa pharmaceuticals in the most comprehensive reference resource on …
Syntex - Wikipedia
- https://en.wikipedia.org/wiki/Syntex
- Syntex. Laboratorios Syntex SA (later Syntex Laboratories, Inc.) was a pharmaceutical company formed in Mexico City in January 1944 by Russell Marker, Emeric Somlo, and Federico Lehmann to manufacture therapeutic steroids from the Mexican yams called cabeza de negro ( Dioscorea mexicana) and Barbasco ( Dioscorea composita ).
Syndexa Pharmaceuticals Corp. Targeting Metabolic Diseases, …
- https://www.fiercebiotech.com/biotech/syndexa-pharmaceuticals-corp-targeting-metabolic-diseases-raises-15m-series-b-financing
- Syndexa Pharmaceuticals Corp. Targeting Metabolic Diseases, Raises $15M Series B Financing Cambridge, MA, May 30, 2008 - Syndexa Pharmaceuticals Corp., a biopharmaceutical company developing
Online Auction of Syndexa Pharmaceuticals Corp
- https://www.thebranfordgroup.com/DNN3/Auction/SYND0713.aspx
- Suggested Riggers: 1) Keith Tobin Extreme Packing Solutions 5 Dodge St Beverly, MA 01915 www.expsinc.com. Contact: Keith Tobin P - 978-232-9190 F - 978-232-9196 [email protected]
Syndexa Pharmaceuticals Corp. Targeting Metabolic Diseases
- https://www.biospace.com/article/releases/syndexa-pharmaceuticals-corp-targeting-metabolic-diseases-raises-15m-series-b-financing-/
- Cambridge, MA, May 30, 2008 – Syndexa Pharmaceuticals Corp., a biopharmaceutical company developing first-in-class drugs to treat metabolic diseases, announced today that it has secured $15M in new financing. The upround was led by new investor Dr. Yalcin Ayasli, a successful entrepreneur in the technology industry and the founder of Hittite ...
Syndax Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/sndax-pharmaceuticals
- Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,
Why Syndax Is Skyrocketing 55% Today | The Motley Fool
- https://www.fool.com/investing/2020/04/28/why-syndax-is-skyrocketing-60-today.aspx
- This morning Syndax Pharmaceuticals (SNDX-3.19%) updated investors with initial data from a phase 1/2 trial evaluating its leukemia drug, and shares are soaring 55% at 12:05 pm EST on Tuesday.
Did you find out everything you wanted about Syndexa Pharmaceuticals Headquarters?
We are sure that the information collected for you about Syndexa Pharmaceuticals Headquarters turned out to be more than enough.
